Satellite Symposia Programme

*as of September 30, 2013 – subject to change

Friday, December 13, 2013

Lunch Satellite Symposium – MSD 


Current and Future Strategies for the Managment of Osteoporosis: Signaling a Change in the Conversation




Pharmacologic Management of Osteoporosis: Risk Benefit Analysis


Alendronate plus Vitamin D3 versus Calcitriol for the Treatment of Osteoporosis in China


Cathepsin K Inhibition: A Novel Approach to the Treatment of Osteoporosis


Q & A and Closing


Saturday, December 14, 2013


Lunch Satellite Symposium – GlaxoSmithKline


Vital Dimensions in Management of Postmenopausal Osteoporosis
Chairs: Dr. Tai-Pang Ip (HKG)


Welcome and Introduction  
Tai-Pang Ip (HKG)


The Role of Cortical and Trabercular Deterioriation in Bone Fragility of Postmenopausal Osteoporosis
Ego Seeman (AUS)


Sustainability of Anti-Fracture Efficacy and Safety of Denosumab in Postmenopausal Osteoporosis
David Kendler (CAN)       


Q & A, Summary and Closing